The largest database of trusted experimental protocols

Amersham hyperfilm ecl

Manufactured by GE Healthcare
Sourced in United States, United Kingdom, Italy, Germany, Sweden, Australia

Amersham Hyperfilm ECL is a high-performance chemiluminescence detection film used in Western blotting applications. It is designed to capture and record light signals generated during the ECL (enhanced chemiluminescence) detection process, providing a visual representation of protein expression levels.

Automatically generated - may contain errors

324 protocols using amersham hyperfilm ecl

1

Radioactive and Non-radioactive Dot Blot Analyses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Radioactive Dot Blot analysis was carried out essentially as described in Fulde et al. (2011 (link)). Briefly, IgGs derived from different host species as well as different subclasses of human IgG were spotted onto a nitrocellulose membrane in a concentration series. The membrane was blocked with 5% skimmed milk at 4°C overnight. The following day, the membrane was washed five times by moderate shaking for 10 min at RT with 10 ml PBS supplemented with 0.05% Tween-20 (PBST). Hybridization with 125I-SCM was performed for 4 h at room temperature (RT). Hybridization (binding) was detected after exposure of X-ray films (Kodak).
Non-radioactive Dot Blot analyses were performed for determination of the minimal IgG interaction sites of the SCM protein. Truncated fragments of SCM were immobilized by spotting onto nitrocellulose membranes. Blocking and washing procedures were performed as described previously (Fulde et al., 2011 (link)). HRP-conjugated rabbit anti-goat antiserum was applied as a ligand for interaction studies. Binding was detected by chemiluminescence determination after incubation of the blots with Pierce® ECL Western Blotting substrate according to the recommendations of the manufacturer. Signal development was performed by exposure of Amersham ECL-Hyperfilm (GE Healthcare) followed by an automated development with a Typon C2 developer (NDTMED-Röntgentechnik).
+ Open protocol
+ Expand
2

Epitope Mapping of Lol p 1 Allergen

Check if the same lab product or an alternative is used in the 5 most similar protocols
The amino acid sequence of Lol p 1 was verified using the UniProtKB (Lol p 1 in UniProtKB/Swiss-Prot) (P14946). SPOT synthesis technology (JPT Peptide Technologies, Germany) was used to bind covalently via C-terminus 63 overlapping synthetic peptides containing 15 amino acids to a Whatman 50 cellulose support (Whatman, UK). Peptides were overlapping by 11 amino acids and acetylated at the N-terminus to prevent degradation.
The membrane was rinsed with HPLC grade methanol (Fisher Scientific Ltd., UK) for 5 min and washed with TRIS buffered saline (TBS) + 0.05% Tween 20 (Sigma) three times. It was followed by blocking with 2% non-fat dry milk concentrate in borate buffer (KPL, UK) diluted with TBS 1/10 for 2 h at room temperature. The wash step was repeated 5 × 5 min to remove excess of blocking buffer. After washing the membrane was incubated with anti-Lol p 1 immunodominant polyclonal IgG sera (1:5,000) (Charles River Laboratories, UK) overnight at 4 °C. On the following day the membrane was washed with TBS + 0.05% Tween 20 (Sigma) five times and probed with the secondary antibody for two hours at room temperature: Goat-anti-Rabbit IgG-HRP (1:20,000) (KPL, UK). The membrane was developed using Prime ECL detection reagent (GE Healthcare, UK) and Amersham ECL Hyperfilm (GE Healthcare, UK).
+ Open protocol
+ Expand
3

Western Blot Analysis of Protein Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine protein levels, N. benthamiana was infiltrated with the relevant Agrobacterium transformants, with leaf tissue sampled 48 h postinfiltration and immediately frozen in liquid nitrogen. Protein extraction was performed by heating ground tissue samples at 95°C for 10 min in 2x SDS gel-loading buffer (100 nm Tris-HCl, pH 6.8, 0.2% [w/v] bromophenol blue, 20% [v/v] glycerol, and 4% [w/v] SDS), followed by centrifugation at 16,000g for 5 min. Proteins were separated on 4% to 12% Bis-Tris PAGE gels with MES buffer, using an X-blot Mini Cell (Thermo Fisher Scientific), followed by transfer to nitrocellulose membrane (GE Healthcare Life Sciences) using an X10 Blot Module (Thermo Fisher Scientific) according to the manufacturer’s instructions. Membranes were stained with Ponceau solution to confirm transfer and even loading.
Membranes were blocked in 4% milk in 1x PBS 0.1% Tween (1xPBS-T) with shaking overnight at 4°C, before incubation with the appropriate antibodies (Santa Cruz sc-40 and sc-9996).
Signal was visualized by incubation with Amersham ECL Prime, on Amersham ECL Hyperfilm (both GE Healthcare Life Sciences), developed with a Compact X4 Automatic Processor (Xograph Healthcare Ltd).
+ Open protocol
+ Expand
4

Quantifying Intracellular Stress Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression of intracellular HMGB1 and HSP70 was semi-quantitatively determined in cell lysates by Western blot technique using standard protocols. To detect the concentration of the DAMP HMGB1 in the supernatant of treated B16 cells, we also used the Western Blot technique. 30 h after the respective treatments, the supernatants were concentrated by centrifugation (Millipore-strainers (NMWI = 3000) 40 min, 4°C, 4000 rpm). 25 µg of protein was loaded on SDS-pages and separation was performed by electrophoresis. After blotting, the protein on nitrocellulose membranes, the proteins of interest were stained with the following antibodies: mouse mAb anti-HMGB1 (abcam, # ab12029) and mouse mAb anti-HSP70 (BD Transduction, # 610608). Anti-mouse HRP conjugated Ab (upstate, Merck Millipore, # 12–349) was used as second step reagent and chemiluminescence was detected with Amersham ECL hyperfilms (GE Healthcare, # 28906836). For detection and quantification of total HSP70 in supernatants of tumor cells, the ELISA DuoSet IC Kit (R&D Systems, # DYC1663) was used according to the manufacturer's instructions.
+ Open protocol
+ Expand
5

Detecting DNA Adducts via Dot-Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
10 µg liver DNA was treated with 0.4 M NaOH/10 mM EDTA for 10 min at 99°C. Afterward, DNA was dot-blotted on nylon membrane with 0.4 M NaOH. Membrane was rinsed in 2× SSC buffer and air-dried. Membrane was blocked with 5% skim milk powder in 1× TBS and 0.5% Tween. For detection of DNA adducts, membrane was incubated overnight with mAb to O6-ethyl-2-deoxyguanosine (EM 21; Squarix). The blots were incubated with anti–mouse secondary HRP-coupled antibodies (GE Healthcare) and developed using Luminata Western HRP Substrate (EMD Millipore) and Amersham ECL Hyperfilms (GE Healthcare). Loading control was performed using methylene blue staining.
+ Open protocol
+ Expand
6

Western Blot Analysis of Cellular Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue was disrupted using a Precellys device (Bertin Technologies) in RIPA buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% Na-deoxycholate, and 0.1% SDS). Protein lysates were quantified using BCA protein assay reagent (Thermo Fisher Scientific). For Western blot analysis, 50 µg protein per sample was loaded. Membranes were blocked with 5% BSA or nonfat dry milk in TBS-T. The following primary antibodies were used: c-Fos (Santa Cruz Biotechnology, Inc.), p-AKT (Cell Signaling Technology), AKT (Cell Signaling Technology), p-Stat3 (Cell Signaling Technology), Stat3 (Cell Signaling Technology), p-JNK (Cell Signaling Technology), JNK (Cell Signaling Technology), Vinculin (Sigma-Aldrich), LXRa (R&D Systems), Srebf1 (Abcam), Srebf2 (Abcam), and Gapdh (Sigma-Aldrich). Blots were incubated with the appropriate secondary HRP-coupled antibody (GE Healthcare and Santa Cruz Biotechnology, Inc.) and developed using Luminata Western HRP Substrate (EMD Millipore) and Amersham ECL Hyperfilms (GE Healthcare) or a ChemiDoc XRS+ imaging system with Image Lab image acquisition and analysis software (Bio-Rad).
+ Open protocol
+ Expand
7

Western Blot Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in CelLytic buffer (Sigma-Aldrich), supplemented with Pierce protease inhibitor (Thermo Fisher Scientific) and PhosSTOP phosphatase inhibitor (Roche, Basel, Switzerland). Protein concentrations were measured by Bradford assay (Bio-Rad, Hercules, CA, USA). A total of 20 µg of protein was electrophoretically separated on 8% or 12% sodium dodecyl SDS-PAGE. The primary and secondary antibodies used are listed in Table S2. The signals were visualized by ECL reagent (AmershamTM ECL Select/Prime Western Blotting Detection System; GE Healthcare), followed by exposure to chemiluminescence film (Amersham HyperfilmTM ECL; GE Healthcare). The Western blot analyses were repeated twice for each protein tested.
+ Open protocol
+ Expand
8

Western Blot Analysis of EMT Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole cell lysates were prepared in RIPA buffer (Sigma) and quantified using Bradford Protein Assay (Bio-Rad). Twenty micrograms of lysates were resolved on Bolt® 4–12% Bis-Tris Plus gels using BoltTM MOPS SDS Running buffer and transferred to a Hybond C super nitrocellulose membrane (GE Healthcare). After blocking to prevent non-specific binding in 5% milk in PBST for 1 h at room temperature, membranes were incubated with the specific primary antibodies overnight at 4 °C. The following primary antibodies were used: E-cadherin (Takara Bio Inc., M106, clone HECD-1, 1:1000 dilution), Occludin (Cell Signaling, #5446, 1:1000 dilution), Vimentin (Cell Signaling, #5741, 1:3000 dilution), ZEB1 (Santa Cruz, sc-25388, 1:500 dilution), SNAI1 (Santa Cruz, sc-28199, 1:500 dilution), LIN28B (Cell Signaling, #4196, 1:1000 dilution), LIN28A (Cell Signaling, #3978, 1:1000 dilution), SMAD2/3 (Cell Signaling, #8685, 1:1000 dilution), β-actin (Abcam, ab8227, 1:200,000 dilution), GAPDH (Santa Cruz, sc-137179, 1:10,000 dilution). Following incubation with the specific HRP-conjugated antibody (Dako, #P0447 or #P0448, 1:2,500 dilution), chemiluminescence signal was detected using AmershamTM ECLTM Western blotting detection reagents (GE Healthcare) and Amersham HyperfilmTM ECL (GE Healthcare). Uncropped scans of the most important blots are shown in Supplementary Fig. 13.
+ Open protocol
+ Expand
9

Immunoprecipitation and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Kc167 cells were collected, washed in PBS and incubated for 30 min in IP buffer (150 mM NaCl, 0.5% NP40, 50 mM Tris-HCl, pH8.0, 1mM EGTA) supplemented with protease inhibitor cocktail (Roche). The extracts were cleared by centrifugation at 13.000g for 15 min at 4°C and subjected to SDS-PAGE (50 μg of proteins par lane) or immunoprecipitation (1 mg per point). For immunoprecipitation, proteins were preadsorbed with 100 μl of sepharose beads slurry for 1h at 4°C before being incubated with 20 μl of anti-GFP (Chromotek), anti-V5 (Sigma-Aldrich) or anti-HA (Covance) antibody coupled to sepharose beads, or with 10 μl of rabbit anti-MLF [19 (link)] or rabbit IgG (SantaCruz) in the presence of 20 μl of protein A sepharose beads (Sigma), for 4h at 4°C. The beads were spun down and washed in IP buffer and immunoprecipitated proteins were processed for SDS-PAGE and Western Blot analyses. Western blots were performed using standard techniques and the blots were developed by photoluminescence procedure using Lumi-LightPLUS Western Blotting Substrate (Roche) and Amersham HyperfilmTM ECL (GE Healthcare) or Chemidoc Touch Imaging System (BioRad). The following antibodies were used for Western blots: anti-V5 (Invitrogen), anti-HA (BioLegend), anti-GFP, anti-tubulin (Sigma-Aldrich), anti-Renilla luciferase (MBL), and anti-MLF [19 (link)].
+ Open protocol
+ Expand
10

Western Blot Analysis of Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated liver (150 mg) and muscle tissues (200 mg) from mice were homogenized with 1.5 mL buffer I (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM Na3VO4, 5 mM NaF, 1 mM PMSF, and 5 µg/ml Leupeptin). The homogenate was centrifuged at 14,500 × g for 20 min at 4°C, and protein concentration was measured using the BCA reagent (Thermo Scientific, Waltham, MA) with BSA as the standard. The lysates (10 µg of total protein) were separated using a 4–15% Mini-PROTEAN® TGXTM precast gel. The resolved proteins were transferred onto a PVDF membrane. The membrane was blocked with 5% BSA in Tris-buffered saline (TBS) containing 0.1% Tween 20 (TBS/T), and incubated overnight at 4°C with primary antibodies in 5% BSA-TBS/T. Immunocomplexes on the membrane were incubated with an HRP-conjugated secondary antibody, visualized using an ImmobilonTM Western Chemiluminescent HRP substrate, and exposed to Amersham HyperfilmTM ECL (GE Healthcare UK Ltd., Buckinghamshire, UK). Specific immunoreaction products were quantitated using the NIH ImageJ software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!